The National Health Insurance Authority (NHIA) will from July this year rollout free treatment for children with sickle cell and cancer registered with the scheme. NHIA has adopted Hydroxyurea, a drug commonly used medicine for patients with SCD in developed countries approved by Ghana’s Food and Drugs Authority in 2018 …
Read More »